sitagliptin sun 50 mg
sun pharmaceutical industries europe b.v. - olanda - sitagliptinum - compr. film. - 50mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)
sitagliptin/clorhidrat de metformin sun 50 mg/1000 mg
sun pharmaceutical industries (europe) b.v. - olanda - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/1000mg - analogi ai glp-1 combinatii de antidiabetice orale
sitagliptin/clorhidrat de metformin sun 50 mg/850 mg
sun pharmaceutical industries (europe) b.v. - olanda - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/850mg - analogi ai glp-1 combinatii de antidiabetice orale
temozolomide sun 100 mg
sun pharmaceutical industries europe b.v. - olanda - temozolomidum - caps. - 100mg - agenti alchilanti alti agenti alchilanti
temozolomide sun 140 mg
sun pharmaceutical industries europe b.v. - olanda - temozolomidum - caps. - 140mg - agenti alchilanti alti agenti alchilanti
temozolomide sun 20 mg
sun pharmaceutical industries europe b.v. - olanda - temozolomidum - caps. - 20mg - agenti alchilanti alti agenti alchilanti
teriparatide sun 20 micrograme/80 microlitri
sun pharmaceutical industries europe b.v. - olanda - teriparatidum - sol inj. in stilou injector (pen) preumplut - 20micrograme/80microlitri - hormoni paratiroidieni si analogi hormoni paratiroidieni si analogi
odomzo
sun pharmaceutical industries europe b.v. - difosfat de sonidegib - carcinomul, celula bazală - agenți antineoplazici - odomzo este indicat pentru tratamentul pacienților adulți cu carcinom bazocelular local avansat (bcc), care nu sunt supuși intervențiilor chirurgicale curative sau radioterapiei.
erlotinib terapia 100 mg
sun pharmaceutical industries (europe) b.v. - olanda - erlotinibum - compr. film. - 100mg - alte antineoplazice inhibitori de protein-kinaza
erlotinib terapia 150 mg
sun pharmaceutical industries (europe) b.v. - olanda - erlotinibum - compr. film. - 150mg - alte antineoplazice inhibitori de protein-kinaza